Feng Deng's most recent trade in Cytek BioSciences Inc was a trade of 4,168,777 Series C Preferred Stock done . Disclosure was reported to the exchange on July 22, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cytek BioSciences Inc | Feng Deng | Director | 22 Jul 2021 | 4,168,777 | 0 | - | - | Series C Preferred Stock | ||
Cytek BioSciences Inc | Feng Deng | Director | 22 Jul 2021 | 4,168,777 | 4,168,777 | - | - | Common Stock | ||
Cytek BioSciences Inc | Feng Deng | Director | 22 Jul 2021 | 443,800 | 0 | - | - | Series D Preferred Stock | ||
Cytek BioSciences Inc | Feng Deng | Director | 22 Jul 2021 | 443,800 | 443,800 | - | - | Common Stock | ||
Cytek BioSciences Inc | Feng Deng | Director | 22 Jul 2021 | 147,933 | 147,933 | - | - | Common Stock | ||
Cytek BioSciences Inc | Feng Deng | Director | 22 Jul 2021 | 147,933 | 0 | - | - | Series A Preferred Stock |